— Know what they know.
Not Investment Advice

000999.SZ

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
1W: -2.8% 1M: -0.9% 3M: -5.8% YTD: -3.0% 1Y: -14.2% 3Y: +18.6% 5Y: +101.7%
¥27.99 ($4.05)
-0.49 (-1.72%)
 
SHZ · Healthcare · Drug Manufacturers - Specialty & Generic · ¥47.4B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥47.4B ($6.9B)
52W Range27.65-35.36154
Volume13,213,412
Avg Volume12,369,858
Beta0.21
Dividend¥0.70
Analyst Ratings
No analyst coverage
Company Info
CEOWen Duo Wu
Employees20,031
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-03-09
Website999.com.cn
Guanlan High-tech Park
Shenzhen 518110
CN
86 755 8336 0999
About China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms